Ethical considerations raised by the approval of interferon beta-1b for the treatment of multiple sclerosis. [electronic resource]
Producer: 19940222Description: 166-70 p. digitalISSN:- 0028-3878
- Bioethics
- Disclosure
- Drug Approval
- Ethical Analysis
- Federal Government
- Government Regulation
- Guidelines as Topic
- Humans
- Interferon-beta -- therapeutic use
- Multicenter Studies as Topic
- Multiple Sclerosis -- drug therapy
- Randomized Controlled Trials as Topic
- Research Subjects
- Risk Assessment
- Therapeutic Human Experimentation
- United States
- Withholding Treatment
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.